Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-03-28

Clinical Trial Update: Green Tea Extract in Treating Patients With Nonmetastatic Bladder Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating green tea extract in nonmetastatic bladder cancer has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Green Tea Extract (Camellia sinensis extract)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Stage I Bladder Cancer, Stage II Bladder Cancer | Phase 2 | Status: COMPLETED | Results posted: 2016-03-28